Cargando…

The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy

ABSTRACT: Chimeric Antigen Receptor (CAR) immunotherapy utilizes genetically-engineered immune cells that express a unique cell surface receptor that combines tumor antigen specificity with immune cell activation. In recent clinical trials, the adoptive transfer of CAR-modified immune cells (includi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Dongfang, Badeti, Saiaditya, Dotti, Gianpietro, Jiang, Jie-gen, Wang, He, Dermody, James, Soteropoulos, Patricia, Streck, Deanna, Birge, Raymond B., Liu, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446110/ https://www.ncbi.nlm.nih.gov/pubmed/32843053 http://dx.doi.org/10.1186/s12964-020-00617-7

Ejemplares similares

Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells
por: Xiong, Wei, et al.
Publicado: (2018)

Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells
por: Xiong, Wei, et al.
Publicado: (2021)

Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
por: Tseng, Hsiang-chi, et al.
Publicado: (2020)

Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
por: Liu, Dongfang, et al.
Publicado: (2017)

Erratum to: Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
por: Liu, Dongfang, et al.
Publicado: (2017)

TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
por: Grada, Zakaria, et al.
Publicado: (2013)

Superior Expansion and Cytotoxicity of Human Primary NK and CAR-NK Cells from Various Sources via Enriched Metabolic Pathways
por: Yang, Yan, et al.
Publicado: (2020)

Learning from TCR Signaling and Immunological Synapse Assembly to Build New Chimeric Antigen Receptors (CARs)
por: Cassioli, Chiara, et al.
Publicado: (2022)

Development of a Novel Human CD147 Transgenic NSG Mouse Model to test SARS-CoV-2 Infection and Immune Responses
por: Badeti, Saiaditya, et al.
Publicado: (2021)

Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance
por: Zhang, Qunfang, et al.
Publicado: (2018)

Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T)
por: Brown, Kevin, et al.
Publicado: (2021)

A bispecific chimeric antigen receptor molecule enhances T cell activation through dual immunological synapse formation and offsets antigen escape in glioblastoma
por: Hegde, Meenakshi, et al.
Publicado: (2015)

Deletion of ER-retention Motif on SARS-CoV-2 Spike Protein Reduces Cell Hybrid During Cell-cell Fusion
por: Chen, Chih-Hsiung, et al.
Publicado: (2021)

Engineering Metabolism of Chimeric Antigen Receptor (CAR) Cells for Developing Efficient Immunotherapies
por: Mangal, Joslyn L., et al.
Publicado: (2021)

T Cell Engaging Immunotherapies, Highlighting Chimeric Antigen Receptor (CAR) T Cell Therapy
por: De Bousser, Elien, et al.
Publicado: (2021)

Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
por: Bonaldo, Giulia, et al.
Publicado: (2021)

Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors
por: Karlsson, Hannah, et al.
Publicado: (2015)

In vitro machine learning-based CAR T immunological synapse quality measurements correlate with patient clinical outcomes
por: Naghizadeh, Alireza, et al.
Publicado: (2022)

Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy – Moving Target for Industry?
por: Salmikangas, Paula, et al.
Publicado: (2018)

Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities
por: Chen, Long, et al.
Publicado: (2022)

Emerging advances in nanobiomaterials-assisted chimeric antigen receptor (CAR)-macrophages for tumor immunotherapy
por: Zhang, Yanan, et al.
Publicado: (2023)

Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell–cell fusion
por: Wang, Xuening, et al.
Publicado: (2021)

Activation and degranulation of CAR-T cells using engineered antigen-presenting cell surfaces
por: Dirar, Qassim, et al.
Publicado: (2020)

The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
por: Schepisi, Giuseppe, et al.
Publicado: (2023)

Chimeric Antigen Receptor beyond CAR-T Cells
por: Qin, Vicky Mengfei, et al.
Publicado: (2021)

Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
por: Galli, Eugenio, et al.
Publicado: (2021)

Humanized Chimeric Antigen Receptor (CAR) T cells
por: Kozani, Pouya Safarzadeh, et al.
Publicado: (2021)

1098. Norovirus Infection in Cancer Patients Undergoing Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T)
por: Kondapi, Divya S, et al.
Publicado: (2020)

CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro
por: Ma, Minh Tuyet, et al.
Publicado: (2021)

Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward
por: Li, Jian, et al.
Publicado: (2018)

Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward
por: Jafarzadeh, Leila, et al.
Publicado: (2020)

Chimeric antigen receptor (CAR) immunotherapy: basic principles, current advances, and future prospects in neuro-oncology
por: Yoo, Hyeon Joo, et al.
Publicado: (2021)

Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
por: Benmebarek, Mohamed-Reda, et al.
Publicado: (2019)

Computationally Guided Design of Single-Chain Variable Fragment Improves Specificity of Chimeric Antigen Receptors
por: Krokhotin, Andrey, et al.
Publicado: (2019)

Metabolic and Mitochondrial Functioning in Chimeric Antigen Receptor (CAR)—T Cells
por: Rad S. M., Ali Hosseini, et al.
Publicado: (2021)

Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer
por: Reppel, Loïc, et al.
Publicado: (2022)

The immunological synapse: the gateway to the HIV reservoir
por: Kulpa, Deanna A, et al.
Publicado: (2013)

Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy
por: Han, Xiao, et al.
Publicado: (2019)

New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future
por: Biagi, Ettore, et al.
Publicado: (2011)

The efficacy of chimeric antigen receptor (CAR) immunotherapy in animal models for solid tumors: A systematic review and meta-analysis
por: Wu, Yingcheng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c5ih6ec9gr7ska74hjiispo25t